Member News Steven Scott Member News Steven Scott

EvoSelect®, A Machine Learning Enzyme Engineering Tool is Released

Isomerase has announced the launch of EvoSelect®, a machine learning-guided enzyme engineering platform designed to accelerate development timelines, enhance performance under industrial conditions, and reduce the cost and complexity of enzyme optimisation. EvoSelect® forms part of Isomerase’s broader IsoZym™ platform, an end-to-end offering that spans protein design, expression, and scale-up.

Read More
Member News Steven Scott Member News Steven Scott

IFS Maven Equity Finance and the Scottish National Investment Bank back NCIMB with £1.7 million investment to drive growth

Aberdeen-based microbiology services provider and internationally recognised bacterial culture collection NCIMB Ltd has secured a £1.7m investment from the Investment Fund for Scotland, managed by Maven Capital Partners (“Maven”) and the Scottish National Investment Bank. The Maven team were first introduced to NCIMB at an IFS Roadshow in Aberdeen, hosted by the British Business Bank.

Read More
IBioIC News Steven Scott IBioIC News Steven Scott

Biotechnology is key to unlocking Grangemouth’s sustainable future

The findings of the Project Willow study highlight several options that can drive the development of a new hub for sustainable industries. Split into three areas – waste and recycling projects, bio-feedstock initiatives and renewable energy – this collection of projects are anticipated to create up to 800 skilled jobs, offering potential new avenues for the current workforce, as well as creating additional economic opportunities.

Read More
IBioIC News Steven Scott IBioIC News Steven Scott

Biotechnology will be a key ingredient for future food security

Scotland’s renowned food and drink industry, led by exports like whisky and seafood, plays a crucial role in the economy, with Scotch whisky exports alone reaching £5.4 billion last year. However, to sustain this success amid climate challenges and a growing global population, embracing bioeconomy innovations—from resilient crops to precision fermentation and sustainable packaging—is essential for future-proofing the industry.

Read More
Industry News Steven Scott Industry News Steven Scott

Scottish Knowledge Exchange Awards 2025 finalists revealed

Revolutionary developments in renewable energy, mental health, education, sport, medicine and food and drink have made it to the finals of the 10th Scottish Knowledge Exchange Awards highlighting the diversity of sectors and disciplines thriving in Scotland. With 32 individuals, teams and projects shortlisted across 10 categories, the 10th anniversary celebration will be the largest to date.

Read More
IBioIC News Steven Scott IBioIC News Steven Scott

INEOS stalwart named as new IBioIC chair

The Industrial Biotechnology Innovation Centre (IBioIC) has appointed Dr Peter Williams, Group Technology Director and Head Of Investor Relations at INEOS, to lead its governing board and support the centre’s continued impact on the growing bioeconomy.

Read More
Member News, Industry News Steven Scott Member News, Industry News Steven Scott

Deputy First Minister & Scottish Enterprise Highlight Success at Celtic Renewables

Deputy First Minister Kate Forbes toured Scotland’s first biorefinery as it reached a milestone in its drive to commercialise ground breaking technology. Celtic Renewables has recently released the first tanker load of green chemicals from its Grangemouth plant, marking the beginning of regular shipments.

Read More
Member News Steven Scott Member News Steven Scott

Concinnity Genetics raises £3m to establish unique RNA-based control systems for precise control of gene therapies in oversubscribed round

Concinnity Genetics, an Edinburgh-based gene control company, is thrilled to announce the closure of its oversubscribed £3m seed funding round. The investment was led by Eos Advisory with support from Scottish Enterprise, Old College Capital (OCC) - the University of Edinburgh’s in-house venture investment fund, and Maven Capital Partners.

Read More